News

News Archive

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

Menarini Ricerche Announces the Latest Findings of its Vaborem™ and Quofenix™ Clinical Studies

Menarini Ricerche Announces the Latest Findings of its Vaborem™ and Quofenix™ Clinical Studies

Menarini Ricerche, the R&D division of the Menarini Group, announces that it has published four abstracts presenting the latest findings related to its meropenem/vaborbactam...
Menarini Ricerche Announces C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer

Menarini Ricerche Announces C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer

Menarini Ricerche, the R&D division of the Menarini Group, announced today that it plans to launch in the second-half of 2020 a new phase Ib/II trial of MEN1611, a potent and...

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More